Total Non-Current Liabilities

$1.17B

Quarterly · Period ending: Jun 30, 2026 · USD

LGND Total Non-Current Liabilities

Latest reported$1.17Bperiod endingJun 30, 2026

LGND Quarterly Total Non-Current Liabilities ($2.20M → $1.17B)

Quarterly total non-current liabilities

High-resolution chart · PNG

LGND total non-current liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ligand Pharmaceuticals Inc Total Non-Current Liabilities — Quarterly (USD)
Period ending	Total Non-Current Liabilities (USD)
Jun 30, 2026	1,171,623,000
Mar 31, 2026	494,116,000
Dec 31, 2025	505,977,999
Sep 30, 2025	496,062,000
Jun 30, 2025	55,341,000
Mar 31, 2025	51,218,000
Dec 31, 2024	74,223,000
Sep 30, 2024	88,916,000
Jun 30, 2024	72,642,000
Mar 31, 2024	89,530,000
Dec 31, 2023	69,521,000
Sep 30, 2023	85,603,000
Jun 30, 2023	63,825,000
Mar 31, 2023	65,830,000
Dec 31, 2022	66,373,000
Sep 30, 2022	99,066,000
Jun 30, 2022	106,070,000
Mar 31, 2022	269,414,000
Dec 31, 2021	434,766,000
Sep 30, 2021	425,293,000
Jun 30, 2021	417,269,000
Mar 31, 2021	453,476,000
Dec 31, 2020	552,649,000
Sep 30, 2020	507,325,000
Jun 30, 2020	518,669,000
Mar 31, 2020	503,583,000
Dec 31, 2019	710,681,000
Sep 30, 2019	661,200,000
Jun 30, 2019	651,398,000
Mar 31, 2019	647,237,000
Dec 31, 2018	617,640,000
Sep 30, 2018	612,878,000
Jun 30, 2018	605,621,000
Mar 31, 2018	10,511,000
Dec 31, 2017	13,506,000
Sep 30, 2017	5,891,000
Jun 30, 2017	4,775,000
Mar 31, 2017	3,950,000
Dec 31, 2016	3,603,000
Sep 30, 2016	4,341,000
Jun 30, 2016	4,536,000
Mar 31, 2016	209,121,000
Dec 31, 2015	208,702,000
Sep 30, 2015	213,266,000
Jun 30, 2015	217,760,000
Mar 31, 2015	212,671,000
Dec 31, 2014	210,842,000
Sep 30, 2014	211,067,000
Jun 30, 2014	18,140,000
Mar 31, 2014	19,465,000
Dec 31, 2013	26,161,000
Sep 30, 2013	24,401,000
Jun 30, 2013	27,732,000
Mar 31, 2013	34,750,000
Dec 31, 2012	42,336,000
Sep 30, 2012	46,392,000
Jun 30, 2012	55,723,000
Mar 31, 2012	65,349,000
Dec 31, 2011	70,061,000
Sep 30, 2011	77,645,000
Jun 30, 2011	79,793,000
Mar 31, 2011	84,574,000
Dec 31, 2010	46,920,000
Sep 30, 2010	85,328,000
Jun 30, 2010	81,343,000
Mar 31, 2010	90,041,000
Dec 31, 2009	85,891,000
Sep 30, 2009	73,536,000
Jun 30, 2009	93,233,000
Mar 31, 2009	101,401,000
Dec 31, 2008	111,199,000
Sep 30, 2008	93,536,000
Jun 30, 2008	96,390,000
Mar 31, 2008	97,420,000
Dec 31, 2007	93,195,000
Sep 30, 2007	125,402,000
Jun 30, 2007	126,186,000
Mar 31, 2007	114,562,000
Dec 31, 2006	127,891,000
Sep 30, 2006	256,642,000
Jun 30, 2006	256,022,000
Mar 31, 2006	257,018,000
Dec 31, 2005	189,827,000
Sep 30, 2005	189,866,000
Jun 30, 2005	190,632,000
Mar 31, 2005	190,993,000
Dec 31, 2004	191,071,000
Sep 30, 2004	176,171,000
Jun 30, 2004	175,848,000
Mar 31, 2004	176,560,000
Dec 31, 2003	176,478,000
Sep 30, 2003	163,911,000
Jun 30, 2003	164,721,000
Mar 31, 2003	165,330,000
Dec 31, 2002	166,059,000
Sep 30, 2002	9,751,000
Jun 30, 2002	8,964,000
Mar 31, 2002	9,569,000
Dec 31, 2001	143,622,000
Sep 30, 2001	144,104,000